Edition:
United Kingdom

Aslan Pharmaceuticals Ltd (ASLN.OQ)

ASLN.OQ on NASDAQ Stock Exchange Global Market

4.79USD
12 Dec 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$4.79
Open
$4.99
Day's High
$4.99
Day's Low
$4.54
Volume
3,751
Avg. Vol
2,611
52-wk High
$10.41
52-wk Low
$4.20

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -2.134
Jun '18 0.00 -2.233
Mar '18 0.00 -1.959
FY 2017 Dec '17 0.00 -3.358
Sep '17 0.00 -1.851
Jun '17 0.00 -2.299
Mar '17 0.00 -2.169
FY 2016 Dec '16
Dec '16 0.00
Sep '16 324.24 1.429
Jun '16 8.21 -8.853
 
*Note: Units in Millions ofTaiwanese Dollars
**Note: Units in Taiwanese Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.13 34.39
P/E High - Last 5 Yrs. -- 40.59 46.24
P/E Low - Last 5 Yrs. -- 23.99 24.59
Beta -- 0.91 0.91
Price to Sales (TTM) 15.98 4.00 6.22
Price to Book (MRQ) 3.32 5.02 5.20
Price to Tangible Book (MRQ) 3.32 5.76 6.74
Price to Cash Flow (TTM) -- 23.20 24.17
% Owned Institutions -- 0.95 1.78

Dividends

  Company industry sector
Dividend Yield -- 1.55 1.44
Dividend Yield - 5 Year Avg -- 1.56 1.46
Dividend 5 Year Growth Rate -- 4.21 4.94
Payout Ratio(TTM) -- 45.68 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -100.00 2.33 8.17
Sales (TTM) vs TTM 1 Yr. Ago 4,341.80 4.80 6.50
Sales - 5 Yr. Growth Rate -- 10.00 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago -104.48 17.26 23.08
EPS (TTM) vs TTM 1 Yr. Ago 81.78 -- --
EPS - 5 Yr. Growth Rate -- 9.88 10.49
Capital Spending - 5 Yr. Growth Rate -- 15.23 14.58

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.20 2.28
Current Ratio (MRQ) 18.10 3.02 3.10
LT Debt to Equity (MRQ) 15.50 8.89 11.49
Total Debt to Equity (MRQ) 15.50 12.69 16.03
Interest Coverage (TTM) -15.86 35.18 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.41 54.44
Gross Margin - 5 Yr. Avg. -- 51.86 52.36
EBITD Margin (TTM) -156.26 -- --
EBITD - 5 Yr. Avg -- 18.41 13.16
Operating Margin (TTM) -157.49 14.42 6.07
Operating Margin - 5 Yr. Avg. -- 14.55 8.47
Pre-Tax Margin (TTM) -160.59 14.96 7.02
Pre-Tax Margin - 5 Yr. Avg. -- 14.97 8.71
Net Profit Margin (TTM) -160.59 11.16 3.12
Net Profit Margin - 5 Yr. Avg. -- 11.23 4.91
Effective Tax Rate (TTM) -- 23.45 23.26
Effective Tax Rate - 5 Yr. Avg. -- 23.65 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 997,016,667 873,056,423
Net Income/Employee (TTM) -- 118,233,002 103,484,349
Receivable Turnover (TTM) 89.37 5.82 5.80
Inventory Turnover (TTM) -- 2.68 3.56
Asset Turnover (TTM) 0.19 0.99 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -30.40 11.98 11.45
Return on Assets - 5 Yr. Avg. -- 13.28 12.50
Return on Investment (TTM) -31.58 15.55 14.96
Return on Investment - 5 Yr. Avg. -- 17.28 16.23
Return on Equity (TTM) -37.22 16.92 16.52
Return on Equity - 5 Yr. Avg. -- 18.21 17.37
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 92.11 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aslan Pharmaceuticals Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 2.19%
# of Holders: 5
Total Shares Held: 3,507,800
3 Mo. Net Change: -23,800
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 1
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.